Exports In 2023, Philippines exported $1.23M in Vaccines, blood, antisera, toxins and cultures, making it the 98th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 554th most exported product in Philippines. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Philippines are: Hong Kong ($465k), Russia ($188k), China ($143k), Vietnam ($96.4k), and Belgium ($85.1k).
The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Philippines between 2022 and 2023 were Russia ($188k), China ($82.9k), and Vietnam ($79.1k).
Imports In 2023, Philippines imported $498M in Vaccines, blood, antisera, toxins and cultures, becoming the 48th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 51st most imported product in Philippines. Philippines imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($146M), India ($56.8M), Switzerland ($46.6M), France ($38.3M), and Germany ($36.7M).
The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Philippines between 2022 and 2023 were Switzerland ($26.4M), India ($24.5M), and Sweden ($10.3M).